[Infographic] BDO Health & Life Sciences Rx: 2025 & Beyond

[Infographic] BDO Health & Life Sciences Rx: 2025 & Beyond

HC_LS_Predictions_InfoG_2018_WEB_1page-x675.jpg

Related Resources

Article

Why and When You Should Perform Pre‑Use/Post‑Sterilization Integrity Testing (PUPSIT)

December 7, 2023
Article

Why and When You Should Perform Pre‑Use/Post‑Sterilization Integrity Testing (PUPSIT)

December 7, 2023

Given that many biologic therapeutics rely on a sterilizing filtration step, it is crucial to be able to effectively evaluate the integrity of sterilizing filters. Historically, the requisite integrity testing was performed post-use.

Read More

Article

PE Add-Ons Drive M&A Transactions

November 22, 2023
Article

PE Add-Ons Drive M&A Transactions

November 22, 2023

Private equity (PE) funds face a new economic reality, defined by higher costs of capital and challenging macro conditions.

Read More

Article

Healthcare’s Guide to Generative AI

November 22, 2023
Article

Healthcare’s Guide to Generative AI

November 22, 2023

The healthcare industry is at the forefront of those experimenting with GenerativeAI and the ways it can be used could revolutionize healthcare as we know it. Learn how your organization can leverage this technology.

Read More

Article

Principles of Mammalian Cell Culture Process Scale‑up

November 21, 2023
Article

Principles of Mammalian Cell Culture Process Scale‑up

November 21, 2023

The BioProcess Technology Group within BDO has direct experience in cell culture scale-up and a broad perspective gained from helping numerous clients with this challenge. Here, we provide an overview of our approach to ensuring success when scaling up cell culture processes, the same principles of which can be applied when transferring processes between different types of bioreactors at the same manufacturing scale.

Read More